TLDR: Arya Health has successfully raised $18.2 million in Series A funding, bringing its total capital to $25 million. The company is leveraging AI-powered digital agents to automate non-clinical administrative tasks in post-acute care, aiming to reduce administrative effort by 50-70%. This funding round, led by ACME Capital, will support Arya Health’s mission to free up healthcare providers to focus on patient care rather than paperwork, addressing significant inefficiencies in the sector.
Arya Health, a pioneering company in healthcare technology, has announced the successful closure of an $18.2 million Series A funding round, elevating its total capital raised to $25 million. This significant investment was spearheaded by ACME Capital, with notable participation from Ridge Ventures, Twelve Below, executives from OpenAI, and several leading post-acute care providers.
The funding is earmarked to further develop and deploy Arya Health’s innovative AI-powered digital agents, which are designed to automate the complex administrative processes within post-acute care. The healthcare sector, particularly post-acute care, faces substantial challenges, with providers reportedly allocating 25 cents of every dollar to administrative tasks rather than direct patient care. This inefficiency is exacerbated by factors such as private equity consolidation demanding operational excellence, persistent caregiver shortages, and an increasingly intricate regulatory landscape. Traditional electronic medical record (EMR) systems, primarily built for clinical documentation, often fall short in coordinating the workforce, leaving front-office teams overwhelmed by scheduling conflicts, compliance tracking, and talent acquisition efforts.
Arya Health directly addresses these pain points by integrating its AI agents alongside existing EMR systems, including prominent platforms like WellSky, HCHB, and AlayaCare. These specialized agents are capable of handling a range of non-clinical administrative functions, such as caregiver scheduling, monitoring license compliance, streamlining onboarding workflows, and managing talent acquisition. The company asserts that its solution can reduce administrative effort by an impressive 50-70%, allowing healthcare professionals to dedicate more time and resources to patient care while maintaining the crucial human element of quality service.
The company has demonstrated remarkable growth, achieving a 6x increase in revenue in 2025, signaling a strong market demand for AI-driven administrative solutions in healthcare. Looking ahead, Arya Health plans to launch an ‘Intake Agent’ in the fourth quarter, which is expected to further accelerate the patient start of care process.
Also Read:
- Guideways Secures Funding to Propel AI-Powered Medtech Regulatory Approvals
- Xunming Biotech Secures Multi-Million Series A Funding to Advance AI-Powered Antibody Design
Kunal Sarda, CEO and Cofounder of Arya Health, emphasized the company’s unique approach, stating, ‘Arya stands out by offering AI agents that actually do the work, not just track it. The platform delivers rapid implementation, immediate value, and fast product evolution, combining deep industry expertise with purpose-built automation for distributed care operations. Most importantly, in a world increasingly littered with narrow AI solutions, Arya is building a complete “digital labor for administration”, with a mandate of becoming the system of action for our customers.’ This vision underscores Arya Health’s commitment to transforming post-acute care administration through comprehensive, intelligent automation.
